SIGNAL-DRIVEN SALES

Turn Funding Signals into Pipeline

Fundz analyzes real-time funding events through YOUR lens to surface companies most likely to buy — with the “why now” built in.

10–25 ICP-matched leads daily • Buyer-intent scoring • No duplicates

Every plan includes:

✓Signal-Driven Leads Based on YOUR ICP

✓Slack + Chrome real-time alerts

✓No duplicates — only new events

INDUSTRY FIRST

ARTMS to Advance ImmunoPET Imaging Isotope with Funding Support from Innovate BC

Mar 02, 2021•over 4 years ago

Vancouver

Description

ARTMS Inc., the global leader in the development and commercialization of novel technologies and products enabling cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce that it received $300,000 funding from Innovate BC as part of its Ignite program. The funding will be combined with over $600,000 from additional sources to further develop and validate the production of zirconium-89 (Zr-89) for use in Positron Emission Tomography (PET) imaging scans of cancer patients eligible for immuno-oncology (IO) therapies.

Company News

(2 articles)

Mon, 04 Mar 2024 08:00:00 GMT

Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform - PR Newswire

Wed, 06 May 2020 07:00:00 GMT

ARTMS and Telix Pharmaceuticals Announce Manufacturing Collaboration - GlobeNewswire

FundzWatch™ Score

Medium Activity